Efficacy, Safety and Immunogenicity of Inactivated SARS-CoV-2 Vaccines (Vero Cell) to Prevent COVID-19 in Healthy Adult Population In Peru Healthy Adult Population In Peru
Clinical trial NCT04612972 · COMPLETED
Trial details
- NCT number
- NCT04612972
- Sponsor
- Universidad Peruana Cayetano Heredia
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-09
- Primary completion
- 2021-02-19
- Enrollment
- 12000
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.